Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) on April 13 in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I...

Inventiva S.A. (Euronext:IVA) raised €35.5 million ($43.8 million) in a private placement through the sale of 5.6 million shares at €6.37. Investors included BVF Partners, Novo Holdings A/S and Sofinnova Crossover I fund. The price...

Cancer, fibrosis and autoimmune company Inventiva S.A. (Euronext:IVA) raised €48 million ($51.2 million) through the sale of 5.7 million shares at €8.50 in an IPO underwritten by Société Générale and KBC Securities on Feb. 14....

Gene therapy company Lysogene S.A. (Euronext:LYS) raised €22.6 million ($24.3 million) through the sale of 3.3 million shares at €6.80 in an IPO underwritten by Société Générale and Gilbert Dupont on Feb. 7. Lysogene said...

Lysogene S.A. (Euronext:LYS) raised EUR 22.6 million ($24.3 million) through the sale of 3.3 million shares at EUR 6.80 in an IPO underwritten by Societe General and Gilbert Dupont. The offering values the company at...